Vertex Pharmaceuticals said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different types of mutations of the ...

The firm is a clinical-stage biopharma developing drug candidates for the treatment of cystic fibrosis conditions. SION is backed by top tier life science venture capital firms and is well ...

Researchers at The University of Manchester in collaboration with Manchester University NHS Foundation Trust (MFT) are launching a new Cystic Fibrosis Innovation Hub to accelerate the development of ...

A case study on how a pharmaceutical company specializing in cystic fibrosis treatments turned to DelveInsight for comprehensive analysis and insights into the digital cystic fibrosis landscape in ...